Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 12, Issue 10, Pages 1585-1596
Publisher
Informa Healthcare
Online
2011-04-20
DOI
10.1517/14656566.2011.564159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of Pulmonary Arterial Hypertension Patients Walking More Than 450 m in 6 Min at Diagnosis
- (2010) Bruno Degano et al. CHEST
- Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects
- (2010) Rebecca Spence et al. CLINICAL DRUG INVESTIGATION
- Pulmonary Arterial Hypertension
- (2009) David B. Badesch et al. CHEST
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
- (2009) N. Galie et al. EUROPEAN HEART JOURNAL
- Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy
- (2009) M. M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
- (2009) A. Lavelle et al. EUROPEAN RESPIRATORY JOURNAL
- Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?
- (2009) M. M. Hoeper EUROPEAN RESPIRATORY JOURNAL
- Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2009) et al. EUROPEAN RESPIRATORY JOURNAL
- Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension
- (2009) Martha Kingman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
- (2009) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
- (2009) Paul M. Hassoun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Updated Clinical Classification of Pulmonary Hypertension
- (2009) Gérald Simonneau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
- (2008) Michael D. McGoon et al. CHEST
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
- Emerging treatments for pulmonary arterial hypertension
- (2008) Dermot S. O'Callaghan Clinical Respiratory Journal
- Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
- (2008) B. Degano et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist
- (2008) M. Iglarz et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
- (2008) N Galiè et al. LANCET
- Pathogenic mechanisms of pulmonary arterial hypertension
- (2007) Stephen Y. Chan et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search